MYCN promotes the expression of miR-421, a microRNA that targets the 3′ untranslated region (UTR) of ATM mRNA, leading to decreased ATM protein levels and enhancing tumor cell survival and genomic instability [74]. Here, ATM is linked to neoplasm.